about
Preconditioning of carbon monoxide releasing molecule-derived CO attenuates LPS-induced activation of HUVECMetabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (prXiang-Qi-Tang and its active components exhibit anti-inflammatory and anticoagulant properties by inhibiting MAPK and NF-κB signaling pathways in LPS-treated rat cardiac microvascular endothelial cells.Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats.
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pathogenesis of vascular disease.
@ast
Pathogenesis of vascular disease.
@en
Pathogenesis of vascular disease.
@nl
type
label
Pathogenesis of vascular disease.
@ast
Pathogenesis of vascular disease.
@en
Pathogenesis of vascular disease.
@nl
prefLabel
Pathogenesis of vascular disease.
@ast
Pathogenesis of vascular disease.
@en
Pathogenesis of vascular disease.
@nl
P2860
P1476
Pathogenesis of vascular disease.
@en
P2093
P2860
P304
P356
10.1046/J.1463-1326.2000.00002.X
P478
P577
2000-11-01T00:00:00Z